Abstract
With the increased acceptance of glycated hemoglobin measurement as the test of choice for the diagnosis and detection of diabetes, doubts which surround the use of the oral glucose tolerance test (OGTT) in detecting disturbances in glucose levels have become even more apparent. Metabolically, there are still arguments to use the OGTT. Epidemiological studies though, have not always supported the efficacy of the OGTT when used for screening in obese patients. In our opinion, current evidence suggests an additive value of the OGTT, its main advantage being the ability to detect stages of pre-diabetes more accurately than HbA1c and the ability to investigate postprandial glucose levels in a physiological way.
Keywords: Oral glucose tolerance test (OGTT), Pre-diabetes, Hemoglobin A1c (HbA1c), Type 2 diabetes mellitus (DM2), IGT, IFG, EGP, post-absorptive state (PAS), HOMA-IR, fasting plasma glucose, insulin secretion (beta-cell function), postprandial glucose, Epidemiological Evidence, T2DM, hemoglobinopathies, uremia, anemia, metformin
Current Diabetes Reviews
Title: The Added Value of Oral Glucose Tolerance Testing in Pre-Diabetes
Volume: 7 Issue: 1
Author(s): Yoeri M. Luijf, Jeroen Hermanides, Mireille J. Serlie, Joost B. Hoekstra and Maarten R. Soeters
Affiliation:
Keywords: Oral glucose tolerance test (OGTT), Pre-diabetes, Hemoglobin A1c (HbA1c), Type 2 diabetes mellitus (DM2), IGT, IFG, EGP, post-absorptive state (PAS), HOMA-IR, fasting plasma glucose, insulin secretion (beta-cell function), postprandial glucose, Epidemiological Evidence, T2DM, hemoglobinopathies, uremia, anemia, metformin
Abstract: With the increased acceptance of glycated hemoglobin measurement as the test of choice for the diagnosis and detection of diabetes, doubts which surround the use of the oral glucose tolerance test (OGTT) in detecting disturbances in glucose levels have become even more apparent. Metabolically, there are still arguments to use the OGTT. Epidemiological studies though, have not always supported the efficacy of the OGTT when used for screening in obese patients. In our opinion, current evidence suggests an additive value of the OGTT, its main advantage being the ability to detect stages of pre-diabetes more accurately than HbA1c and the ability to investigate postprandial glucose levels in a physiological way.
Export Options
About this article
Cite this article as:
M. Luijf Yoeri, Hermanides Jeroen, J. Serlie Mireille, B. Hoekstra Joost and R. Soeters Maarten, The Added Value of Oral Glucose Tolerance Testing in Pre-Diabetes, Current Diabetes Reviews 2011; 7 (1) . https://dx.doi.org/10.2174/157339911794273946
DOI https://dx.doi.org/10.2174/157339911794273946 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
Coronaviruses Peptide Immunotherapies in Type 1 Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Design of Novel Biphenyl-2-thioxothiazolidin-4-one Derivatives as Potential Protein Tyrosine Phosphatase (PTP)-1B Inhibitors Using Molecular Docking Study
Letters in Drug Design & Discovery The Synergistic Use of Computation, Chemistry and Biology to Discover Novel Peptide-Based Drugs: The Time is Right
Current Pharmaceutical Design New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection
Current Diabetes Reviews Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment
Current Alzheimer Research Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Designing Peptidomimetics
Current Topics in Medicinal Chemistry Growth Hormone and Insulin-Like Growth Factor-I as an Endocrine Axis in Alzheimers Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis and Bioactivity Evaluation of Dipeptidyl Peptidase IV Resistant Glucagon-like Peptide-1 Analogues
Protein & Peptide Letters Current Problems with Non-Specific COX Inhibitors
Current Pharmaceutical Design Microbial Agents, Immune Function and Atheromatosis: The Chlamydophila pneumoniae Role
Current Immunology Reviews (Discontinued) Involvement of L-Carnitine in Cellular Metabolism: Beyond Acyl-CoA Transport
Mini-Reviews in Medicinal Chemistry Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies
Current Aging Science Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Recommendations for the Treatment of Hypertension in Elderly People
Cardiovascular & Hematological Agents in Medicinal Chemistry Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Current Alzheimer Research Alternative Medicine as a Treatment Option for COVID-19
Current Traditional Medicine